Skip to main content
. 2020 Apr 15;11(4):137–149. doi: 10.4239/wjd.v11.i4.137

Table 1.

Definitions of the primary efficacy outcome in each of the included trials

Trial Definition of primary efficacy outcome
CHANCE 2013 Stroke recurrence (ischemic or hemorrhagic).
CHARISM 2006 The composite of myocardial infarction, stroke, or death from cardiovascular causes.
CREDO 2002 The composite of death, myocardial infarction, and stroke.
CURE 2001 The composite of myocardial infarction, stroke, or death from cardiovascular causes.
POINT 2018 The composite of ischemic stroke, myocardial infarction, or death from ischemic vascular causes.
SPS3 2012 Stroke recurrence (ischemic or hemorrhagic).